[{"_1":2,"_88":-5,"_89":-5},"loaderData",{"_3":4,"_26":27},"root",{"_5":6,"_17":10,"_18":19,"_20":21,"_22":10,"_23":-5,"_24":-5,"_25":10},"user",{"_7":8,"_9":10,"_11":10,"_12":-5,"_13":-5,"_14":15,"_16":-5},"roles",[],"isAuthenticated",false,"isPremium","planName","subscriptionStatus","featureFlags",{},"insightsBudget","isDevelopmentHost","userPreferences",{},"recaptchaSiteKey","6LcvOJcUAAAAAHsB-gPGfGktcRlKpH7OTIU_dMTD","isImpersonating","impersonation","affiliateStatus","isFreedomPortal","routes/v2/article/layout",{"_28":29,"_30":31},"notFound",true,"relatedArticles",[32,76],{"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":46,"_47":48,"_49":50,"_51":52,"_53":54,"_55":56,"_57":58,"_59":60,"_61":62,"_63":64,"_65":66,"_67":68,"_69":70,"_71":72,"_73":74,"_75":74},"mediaId",6379550,"mediaKeyId","2135819-8f6038ad7263bb38f7c3fa32b2c010d8","parentId",2135819,"title","Minnesota–Mayo partnership: committee hears history, governance and a request for detailed accounting of state funds","audioSeconds",797,"startMs",3699000,"endMs",4496000,"viewUrl","/Search/View?dp=1&key=2135819-8f6038ad7263bb38f7c3fa32b2c010d8&start=3699&end=4496","thumbnailUrl","https://assets.pipeline.soar.com/2135819-8f6038ad7263bb38f7c3fa32b2c010d8/thumbnail_3699000.jpg","articleUrl","/articles/6379550/Minnesota/MinnesotaMayo-partnership-committee-hears-history-governance-and-a-request-for-detailed-accounting-of-state-funds","mediaUrl","https://secure.pipeline.soar.com/6379550-facd98b5a6acf56430feee87833cb9e7/orig.mp4?Expires=1771199948&Signature=Frh9Kn9k2v7SstPez5bgKyiy2G0mxcPdgcgncRxLNSzE3WazcOk1623i~MmflXva6VHmRo2u79JM7PjQWzajIirPG8~C50HqvekVHvpeEKYTpzMgfGN7lPJBvosOn8hxJpF7hoFYL1eCxJvDh1xFqBH6FChVVDSJvqqowZtXrUneBdPREuBtbTYEVhcGKCrgjfakiMgUJbsAHJHtns3hQJaS1duwQkAz3MrUkHz4-UlRuxzPqPiNSsFDjHZwUAu6obU4Qu0ePfSDk4TUmfNe2sg1NzJTUv4PNt7brl21ND6V~pyz5XjPc2td-mrC85IlzAlRqUxzpjHg5BUe38KPxg__&Key-Pair-Id=KUT5TJCACFTXG","author","MNHouseInfo","date","2025-01-21T00:00:00Z","article","University of Minnesota and Mayo Clinic officials told the House Higher Education Finance and Policy Committee that the Minnesota Partnership for Biotechnology and Medical Genomics — a joint program that began in 2004 — has supported research, commercialization and workforce development through competitive awards and multi‑institution governance.

The partnership’s origin and funding: Peter Crawford, vice dean for research at the University of Minnesota Medical School, said the program began with a 2003–2004 state gift of $2 million that was matched by the university and Mayo Clinic. He told the committee that since fiscal year 2015 the program has been funded at nearly $8 million per year as a legislated biennial appropriation; $500,000 of that annual amount is earmarked for Alzheimer’s disease and related dementia research. Crawford said the partnership has distributed roughly $167 million to 279 research and infrastructure projects since inception (the committee requested official program accounting to confirm totals).

Governance and oversight: Nathan Wiedemann (director of translation at Mayo Clinic and Mayo’s administrative lead for the partnership) described a three-tier oversight structure — an executive committee, program leadership and a joint program management team — with scientific review, quarterly budget reviews and at least five years of post‑award tracking for outcomes (publications, follow‑on funding, commercialization, new companies). Wiedemann and Crawford said the partnership files an annual fiscal-year report to the governor’s office.

Examples and outcomes: The presenters cited multiple translational outcomes that advanced to clinical testing or commercial use. Examples named during testimony included:
- VoxiHealth: miniaturized radiation-dosimetry sensors and a small-molecule profiling platform used in early cancer detection and partnered with device companies.
- Numeric: a visualized needle‑thoracostomy aid intended to improve emergency management of tension pneumothorax in prehospital and transport settings.
- Myogenica: an investigational product using induced pluripotent cell technology being advanced toward clinical trials for Duchenne muscular dystrophy.
Crawford said the program also supports projects spanning obesity and dementia links, inflammation and cardiovascular disease, vaccine response, and pulmonary hypertension.

What Mayo contributes: Committee members asked whether Mayo provides direct cash in addition to administrative support. Dr. Y. S. Prakash, Mayo’s vice dean of research, said Mayo contributes substantial in‑kind resources — leadership time, staff, access to laboratories and Mayo Clinic Ventures for commercialization support — and that the institution’s primary contribution to the partnership is those resources rather than a specified direct cash match for every state dollar.

Lawmakers’ concerns and committee direction: Representative Robbins and other members told presenters they wanted more granular answers about what the state appropriation purchases — which projects and amounts — and asked for detailed reporting tied to the $16 million appropriated across the current biennium (the presenters confirmed they would provide greater detail and annual award accounting). Representative Scott asked whether Minnesota Partnership funds have been used for pediatric gender‑affirmation surgery research; Crawford and Wiedemann said the partnership has not funded such research and that they would follow up on any institution‑wide activity outside the partnership’s awards.

Next steps: The committee asked the University of Minnesota and Mayo Clinic to provide a more detailed fiscal accounting of state appropriations to the partnership, line‑item descriptions of award recipients and program outcomes, and any additional information elected members have requested for budget review.","mediaType","Video","parentTitle","House Higher Education Finance and Policy Committee 1/21/25","oneSentenceSummary","University of Minnesota and Mayo Clinic officials summarized the Minnesota Partnership for Biotechnology and Medical Genomics, noting the program’s origin in a 2004 state gift, a current legislated biennial appropriation that provides roughly $8 million per year (with $500,000 earmarked for Alzheimer’s research), and that the partnership has funded dozens of translational projects.","taxTitle","2025 Legislature MN, Minnesota","taxId",77817,"location","Minnesota","headline","","shortSummary",{"_33":77,"_35":36,"_37":38,"_39":78,"_41":79,"_43":80,"_45":81,"_47":82,"_49":83,"_51":84,"_53":85,"_55":56,"_57":58,"_59":86,"_61":62,"_63":64,"_65":87,"_67":68,"_69":70,"_71":72,"_73":74,"_75":74},6379554,"University of Minnesota tells House committee its research enterprise tops $1.3 billion and fuels startups",690,120000,810000,"/Search/View?dp=1&key=2135819-8f6038ad7263bb38f7c3fa32b2c010d8&start=120&end=810","https://assets.pipeline.soar.com/2135819-8f6038ad7263bb38f7c3fa32b2c010d8/thumbnail_120000.jpg","/articles/6379554/Minnesota/University-of-Minnesota-tells-House-committee-its-research-enterprise-tops-13-billion-and-fuels-startups","https://secure.pipeline.soar.com/6379554-b19334b6ed79e31b6e1580bd0c847888/orig.mp4?Expires=1771199948&Signature=KGkyUsRFVWSbnh0qaRbiwmljvBA7JuoF0QPU9L0C6nXLlGKmMaTDAowWSTKpfaTrKhdp5pRtZBnkvlmbzdY55M6cvbM6iDBMfBLDiwcZen7KnNkIbaKOwLwi32u5aoMPbPP-bt~XRat7Z95XB248svlwjpwH5OekFYb2dBJL3RnBuZvEBVAelAMxD3wvI7tM0ea3nw~pVeW2hQ3-moyHciGJvwRjxAlAZqvc4YfHoMGPDUsVcYQlgWEklGxw1XpK~3o3oCU6Vngl0JAn~gE2uy~VNFc6pQS0uhumRYGGSIRwcqq04hftx2oxvQchdok7F1MDwgBeinUdaFalrbDigg__&Key-Pair-Id=KUT5TJCACFTXG","The University of Minnesota told the House Higher Education Finance and Policy Committee on the day’s agenda that its research enterprise had $1.32 billion in research expenditures in 2023 and drives roughly $11.5 billion in statewide annual economic impact.

The university’s Research and Innovation Office representatives said the system spans five campuses, concentrates federal support (with the National Institutes of Health the single largest federal funder), and converts some research into startups and commercial products. “We are an over a $1,000,000,000 research enterprise that benefits the state and creates opportunities for our students,” Kimberly Kirkpatrick said during the committee presentation.

Why it matters: Committee members said they want more detail on how state research dollars are spent and on outcomes that return value to Minnesota. Several lawmakers pressed presenters for follow-up numbers — including the share of research funding that comes from state sources, the markets for crop-research products, and intellectual-property protections for high-value technologies.

Most important facts: Kirkpatrick told the committee the systemwide research expenditures reported to the National Science Foundation were about $1.32 billion in 2023 (the university system figure she cited was $1.35 billion). She said federal funding is the largest source and that the university’s overall economic impact study estimates $11.5 billion in annual impact. She highlighted the Clinical and Translational Science Institute (CTSI), a NIH-funded award of $59.2 million over seven years, as a recent major federal award intended to accelerate clinical trials and translation into patient care.

The presentation described programmatic highlights and private partnerships: the Forever Green initiative, originally funded with a $5 million Minnesota Department of Agriculture grant and later supplemented by a $2.5 million Cargill contribution and a recent $10 million Department of Energy award, supports development of winter cover crops for low-carbon fuels and soil-health benefits. The university also emphasized technology commercialization: Rick Huebsch, who leads technology commercialization, said the university has spun out hundreds of startups since 2006 and is the state’s single largest source of startup companies; he cited “NIRON Magnetics” (a university spinout working on non–rare-earth permanent magnets) as an example of a technology the state has helped scale, with a pilot facility in North Minneapolis and a planned scale-up in Sartell with roughly 175 projected jobs.

Lawmakers’ questions and follow-up requests: Members pressed for more granular accounting. Chair Eric Rehrig asked what portion of research revenue was state-sourced; Kirkpatrick estimated the state portion at roughly 8–10 percent of total research funding and said she would provide an exact dollar figure. Representative Allen and others asked about specific research sites (for example, land sales and mineral-rights proceeds at a Rosemount site) and were told those details would be provided after the meeting. Representative Scott asked about protections against foreign intellectual-property theft; Huebsch described standard university practices (patent filings, training and compliance) and said the office files protections in countries where commercialization is expected.

What the presentation did not resolve: Presenters answered many high-level questions but repeatedly offered to follow up with project-level details — for example, market plans for crops such as winter camelina and pennycress, the exact dollar amount of state funding in FY2023, and turnover rates for researchers. Committee members asked for that follow-up during the university’s multi‑day return to the committee.

Next steps: Committee members directed the university to bring back more specific breakdowns of funding sources, the results or commercialization outcomes tied to state dollars, and answers about specific campus asset sales. The university agreed to follow up in writing and in future sessions.","University research officials told the House Higher Education Finance and Policy Committee the system recorded about $1.32 billion in research expenditures in 2023 and that federal grants — chiefly from the National Institutes of Health — supply the largest share of that funding.","actionData","errors"]

Article not found

Minnesota–Mayo partnership: committee hears history, governance and a request for detailed accounting of state funds

University of Minnesota tells House committee its research enterprise tops $1.3 billion and fuels startups